No insider purchase over the last 90 days. The latest, by WIRTH JAMES F, was filed 31 May 2024.
This page follows insider dealings at Innsuites Hospitality Trust as filed with SEC (Form 4), a company from the Health Care sector. Between 21 October 2025 and 21 October 2026, 4 insiders published 24 filings.
All open-market trades in the period are sales: 19 sales worth €5.2B, by 2 insiders, with no purchase on record. No amount is published for 1 filing, which the totals therefore leave out. One trade stands out by size: a sale of €1.6B from Wirth James F, disclosed on 24 August 2026.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 24 filings, this issuer sits above that mark. Our records for Innsuites Hospitality Trust go back to 2016, with 38 purchases and 36 sales on the open market in total. For the fiscal year to 31 January 2026, the annual 10-K/A puts revenue at 7.6 m USD and net income at -1.4 m USD.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended January 2026 · cache
25 of 84 declarations
Innsuites Hospitality Trust is a real estate investment trust focused on hospitality. It specializes in the acquisition and management of hotels and related properties.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Jan 2026 | 7.6 m USD | -1.4 m USD | -0.16 USD | 10-K/A |
| Jan 2025 | 7.6 m USD | -1.4 m USD | -0.16 USD | 10-K |
| Jan 2024 | 7.5 m USD | 203,880 USD | 0.02 USD | 10-K |
| Jan 2023 | 7.1 m USD | 523,171 USD | 0.06 USD | 10-K |
| Jan 2022 | 6.7 m USD | 254,144 USD | n.d. | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.